Breaking
Medicare GLP-1 Coverage Effective July 1, 2026. Wegovy, Zepbound & Foundayo now covered at $50/month for qualifying Medicare beneficiaries. Summit's T3 database is the new patient acquisition audience for GLP-1 brands.
Learn More →
SESSION LIVE
PLATFORM · DATA LAYER

From Patient Intent to Rx Fulfillment

Summit's data layer maps the entire patient acquisition funnel — from first intent signal through verified fulfillment — across the largest exclusive condition-confirmed cohort in healthcare.

15.3M+ T3·Intent-Qualified Records
218,071 T2·Dx-Qualified Records
140,216 T1·Tx-Verified Records
46,837 HCP Verified Prescribers
20-Year Exclusive License
1,008,348 Annual Rx Events
PROVENANCE

How This Data Was Built

Summit's dataset wasn't aggregated — it was operationally generated. Three healthcare operating entities ran condition-specific patient acquisition campaigns for a decade. Every record traces back to a real patient who raised their hand on an unbranded campaign — not a claim, not a model, not a list purchase.

The result is a patient intent layer — not a list. Every record represents a real, diagnosed patient who self-identified with a chronic condition by completing an unbranded supply, Rx, or coverage intake form, or calling in on a click-to-call campaign. First-party, post-conversion, and consented — captured at the moment of in-market shopping between prescriptions, refills, and coverage decisions.

DATA TIERS

Four tiers. Increasing depth at each level.

HCP
Verified Prescribers
46,837

HCP prescribers linked to T1/T2 patients. National provider identifier matched, specialty-confirmed. Warm prescribers, not cold specialty codes.

T3
Qualified Intent
15.3M+

Form-completed or click-to-call patient inquiries. Self-identified condition + intent. The new patient acquisition cohort and gold seed for predictive AI.

T2
Dx-Qualified
218,071

Form completed → called → clinically confirmed → failed on logistics, not qualification. Real, diagnosed, in-market patients blocked by process.

T1
Tx-Verified
140,216

Form completed → called → clinically qualified → supply fulfilled. Closed-loop fulfillment captured against signed patient intent.

Patient Enrichment Layer

Demographic + area health context attached to every record

15.3M Records with full demographic context
74.5% Hashed email coverage for identity-graph match
15 Linked attributes per record (geo, comorbidity, payer, & more)
THE INTENT LAYER

The Intent Layer

12.17M unique patients
2.15M inbound CTC
100% hashed phone
140,216 T3→T1 conversions

15.3M condition-confirmed inquiries across 12.17M unique patients, 2016–2026 — every one self-identified at the point of in-market shopping. Post-conversion, consented, identity on file. The funnel itself, not a behavioral proxy of it.

USE CASE 01

Direct Activation

Hashed email + phone match into any DSP. Every impression hits a patient who already proved condition-specific intent — not a behavioral guess.

USE CASE 02

Seed + Lookalike

Feed T3 as a verified seed into predictive audience models, AI training, and lookalike expansion. Post-conversion, condition-confirmed, self-identified — not a behavioral proxy.

USE CASE 03

Outcomes + Suppression

Match T3 to pharmacy claims for closed-loop attribution from intent to fill. Or suppress T3 from buys you don't want to re-target — never burn CPM on hand-raisers.

APEX SEGMENT OVERLAYS

15M patients · 75M+ activation paths across 5–7 therapeutic categories each.

Summit patients don't map to one drug category — they map to 5–7 simultaneously. A single record can seed a GLP-1 campaign, a cardiovascular campaign, a hypertension campaign, an antidepressant campaign, and a sleep-disorder campaign at the same time. Real patients on multiple condition pathways — not modeled prevalence.

CARDIO-METABOLIC STACK

Cardio-Metabolic

Diabetes ∩ Hypertension ∩ Hyperlipidemia ∩ Heart Failure / ACE inhibitors, ARBs, statins, anticoagulants, SGLT2 — five activatable categories per patient.

GLP-1 BRIDGE OVERLAYS

GLP-1 Bridge

BMI ≥27 ∩ T2D ∩ CVD ∩ OSA / Wegovy, Zepbound, Foundayo cohorts ready July 1, 2026. 58,681 confirmed AFib · 12,906 diabetes+cardiac overlap.

OSA–GLP-1 CROSSOVER

OSA–GLP-1 Crossover

OSA ∩ Obesity ∩ Resistant HTN / Highest-LTV cohort for Zepbound dual-indication. Phone-hash-only segment perfect for CTV + audio activation.

ACTIVATION

Three Activation Layers

01

STEP 01

Audience Identification

Match Summit's 15.3M record cohort against your campaign's eligibility criteria. Output: a deterministic, condition-specific audience.

02

STEP 02

Channel Activation

Push to your DSP, identity platform, or programmatic stack. Compatible with LiveRamp, Epsilon CORE ID, native DSP graphs, and your clean room.

03

STEP 03

Closed-Loop Attribution

Match-back to confirmed Rx fulfillment events. Closed-loop attribution from impression to therapy initiation.

USE CASES

Eight categories of activation across the patient-acquisition funnel.

Every category uses the same underlying cohort and identity layer.

USE CASE · 01

New Patient Acquisition

15.3M condition-confirmed hand-raisers. Reach diagnosed patients before they walk into the doctor's office — upstream of the next claim, not downstream of the last.

USE CASE · 02

Seed Audiences

T3 = the gold seed for predictive AI and lookalike expansion. Post-conversion, condition-confirmed, identity on file — not a behavioral proxy.

USE CASE · 03

AI Training

First-party patient records with explicit consent. The cleanest training data in healthcare for in-market intent models.

USE CASE · 04

Adherence Lift

30,797 patients in active supply 3+ years. Activate patients in the early refill window — before they fall off therapy.

USE CASE · 05

Brand Switching

Identify patients on competitor therapies who match your switching profile — comorbidity-aware, payer-aware.

USE CASE · 06

Suppression

Pull T3 out of impression buys — don't burn CPM on hand-raisers you already converted.

USE CASE · 07

Closed-Loop Attribution

140,216 T3→T1 conversions on file. Match impression to confirmed Rx fill with a single identity graph.

USE CASE · 08

HCP Engagement

166,464 NPIs linked to confirmed patients — warm prescribers, not cold specialty codes.

CROSS-CONDITION INTELLIGENCE

Summit's identity layer tracks the same patient across nine condition pathways — exposing cross-condition signal that single-cohort datasets miss entirely.

6,819,000 Diabetes
2,015,000 Sleep Apnea
2,100,000 Cardiac
1,240,000 GLP-1 Inquiries
433,128 HCP Claims Match
580,000 Polypharmacy
166,464 HCPs
58,681 AFib Confirmed
12,906 Diabetic+Cardiac
2,150,000 Inbound CTC
19,470 GLP-1 Shipped
1,408,000 Diabetes+HTN
1,150,000 OSA+Obesity
220,000 Territory Mapping
140,216 T3→T1 Conversions

Ready to see what Summit data can do for your campaigns?

Talk to our team about your campaign and we'll be in touch within one business day.